These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
687 related articles for article (PubMed ID: 22291913)
1. A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs. Lassen KG; Hebbeler AM; Bhattacharyya D; Lobritz MA; Greene WC PLoS One; 2012; 7(1):e30176. PubMed ID: 22291913 [TBL] [Abstract][Full Text] [Related]
2. Modeling HIV-1 Latency Using Primary CD4 Takata H; Kessing C; Sy A; Lima N; Sciumbata J; Mori L; Jones RB; Chomont N; Michael NL; Valente S; Trautmann L J Virol; 2019 Jun; 93(11):. PubMed ID: 30918072 [TBL] [Abstract][Full Text] [Related]
3. Phenotypic analysis of the unstimulated in vivo HIV CD4 T cell reservoir. Neidleman J; Luo X; Frouard J; Xie G; Hsiao F; Ma T; Morcilla V; Lee A; Telwatte S; Thomas R; Tamaki W; Wheeler B; Hoh R; Somsouk M; Vohra P; Milush J; James KS; Archin NM; Hunt PW; Deeks SG; Yukl SA; Palmer S; Greene WC; Roan NR Elife; 2020 Sep; 9():. PubMed ID: 32990219 [TBL] [Abstract][Full Text] [Related]
4. The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and Reversed. Rezaei SD; Lu HK; Chang JJ; Rhodes A; Lewin SR; Cameron PU J Virol; 2018 Jul; 92(13):. PubMed ID: 29643247 [TBL] [Abstract][Full Text] [Related]
5. High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects. Iglesias-Ussel M; Vandergeeten C; Marchionni L; Chomont N; Romerio F J Virol; 2013 Aug; 87(16):9148-58. PubMed ID: 23760244 [TBL] [Abstract][Full Text] [Related]
6. Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4 Battivelli E; Dahabieh MS; Abdel-Mohsen M; Svensson JP; Tojal Da Silva I; Cohn LB; Gramatica A; Deeks S; Greene WC; Pillai SK; Verdin E Elife; 2018 May; 7():. PubMed ID: 29714165 [TBL] [Abstract][Full Text] [Related]
7. Activation of Latent HIV-1 T Cell Reservoirs with a Combination of Innate Immune and Epigenetic Regulators. Palermo E; Acchioni C; Di Carlo D; Zevini A; Muscolini M; Ferrari M; Castiello L; Virtuoso S; Borsetti A; Antonelli G; Turriziani O; Sgarbanti M; Hiscott J J Virol; 2019 Nov; 93(21):. PubMed ID: 31413127 [TBL] [Abstract][Full Text] [Related]
9. Dynamics of HIV latency and reactivation in a primary CD4+ T cell model. Mohammadi P; di Iulio J; Muñoz M; Martinez R; Bartha I; Cavassini M; Thorball C; Fellay J; Beerenwinkel N; Ciuffi A; Telenti A PLoS Pathog; 2014 May; 10(5):e1004156. PubMed ID: 24875931 [TBL] [Abstract][Full Text] [Related]
10. LGIT In Vitro Latency Model in Primary and T Cell Lines to Test HIV-1 Reactivation Compounds. Jung U; Takahashi M; Rossi JJ; Burnett JC Methods Mol Biol; 2016; 1354():255-64. PubMed ID: 26714717 [TBL] [Abstract][Full Text] [Related]
11. Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells. Bosque A; Planelles V Blood; 2009 Jan; 113(1):58-65. PubMed ID: 18849485 [TBL] [Abstract][Full Text] [Related]
12. Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4+ T cells. Saleh S; Wightman F; Ramanayake S; Alexander M; Kumar N; Khoury G; Pereira C; Purcell D; Cameron PU; Lewin SR Retrovirology; 2011 Oct; 8():80. PubMed ID: 21992606 [TBL] [Abstract][Full Text] [Related]
13. Reactivation Kinetics of HIV-1 and Susceptibility of Reactivated Latently Infected CD4+ T Cells to HIV-1-Specific CD8+ T Cells. Walker-Sperling VE; Cohen VJ; Tarwater PM; Blankson JN J Virol; 2015 Sep; 89(18):9631-8. PubMed ID: 26178987 [TBL] [Abstract][Full Text] [Related]
14. Humanized Mouse Model of HIV-1 Latency with Enrichment of Latent Virus in PD-1 Llewellyn GN; Seclén E; Wietgrefe S; Liu S; Chateau M; Pei H; Perkey K; Marsden MD; Hinkley SJ; Paschon DE; Holmes MC; Zack JA; Louie SG; Haase AT; Cannon PM J Virol; 2019 May; 93(10):. PubMed ID: 30842333 [TBL] [Abstract][Full Text] [Related]
15. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4 Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S J Virol; 2018 May; 92(9):. PubMed ID: 29444937 [TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of Latency Establishment in the Different Human CD4 Butta GM; Bozzi G; Gallo G; Copaloni G; Cordiglieri C; Crosti M; Mancino M; Prati D; Simon V; Gori A; Bandera A; De Francesco R; Manganaro L J Virol; 2022 May; 96(10):e0037922. PubMed ID: 35499323 [TBL] [Abstract][Full Text] [Related]
17. α Cheung KW; Wu T; Ho SF; Wong YC; Liu L; Wang H; Chen Z J Virol; 2018 Apr; 92(8):. PubMed ID: 29386290 [TBL] [Abstract][Full Text] [Related]
18. The Effect of JAK1/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency. de Armas LR; Gavegnano C; Pallikkuth S; Rinaldi S; Pan L; Battivelli E; Verdin E; Younis RT; Pahwa R; Williams SL; Schinazi RF; Pahwa S Front Immunol; 2021; 12():720697. PubMed ID: 34531866 [TBL] [Abstract][Full Text] [Related]
19. Establishment and Reversal of HIV-1 Latency in Naive and Central Memory CD4+ T Cells In Vitro. Zerbato JM; Serrao E; Lenzi G; Kim B; Ambrose Z; Watkins SC; Engelman AN; Sluis-Cremer N J Virol; 2016 Sep; 90(18):8059-73. PubMed ID: 27356901 [TBL] [Abstract][Full Text] [Related]
20. Experimental approaches to the study of HIV-1 latency. Han Y; Wind-Rotolo M; Yang HC; Siliciano JD; Siliciano RF Nat Rev Microbiol; 2007 Feb; 5(2):95-106. PubMed ID: 17224919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]